The clinicopathologic spectrum and management of nonalcoholic fatty liver disease

被引:59
作者
Contos, MJ
Sanyal, TJ
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pathol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Gastroenterol, Richmond, VA 23298 USA
关键词
nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; fatty liver; insulin resistance; diabetes mellitus; obesity;
D O I
10.1097/00125480-200201000-00005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nonalcoholic fatty liver disease (NAFD) comprises a spectrum of conditions characterized by the presence of predominantly macrovesicular fatty change in the liver and the absence of alcohol consumption in amounts considered detrimental to the liver. The histologic spectrum of NAFLD includes fatty liver alone or steatohepatitis (NASH). Nonalcoholic steatohepatitis is associated with increasing fibrosis is sonic cases and may progress to cirrhosis. Nonalcoholic fatty liver disease is often associated with insulin resistance. It is likely that there are one or more additional pathophysiologic defects in those with NASH, rendering them more susceptible to injury from oxidative stress, The clinical and histologic features of NASH are described, and an approach to the diagnosis and treatment of NAFLD is provided.
引用
收藏
页码:37 / 51
页数:15
相关论文
共 104 条
[1]   Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient [J].
Acosta, BS ;
Grimsley, EW .
SOUTHERN MEDICAL JOURNAL, 1999, 92 (04) :421-423
[2]   Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia [J].
Ahmed, A ;
Keeffe, EB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12) :2598-2599
[3]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[4]   CORRELATIONS BETWEEN FATTY-ACID AND GLUCOSE-METABOLISM - POTENTIAL EXPLANATION OF INSULIN-RESISTANCE OF PUBERTY [J].
ARSLANIAN, SA ;
KALHAN, SC .
DIABETES, 1994, 43 (07) :908-914
[5]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[6]   IDIOPATHIC STEATOHEPATITIS IN CHILDHOOD - A MULTICENTER RETROSPECTIVE STUDY [J].
BALDRIDGE, AD ;
PEREZATAYDE, AR ;
GRAEMECOOK, F ;
HIGGINS, L ;
LAVINE, JE .
JOURNAL OF PEDIATRICS, 1995, 127 (05) :700-704
[7]   Ubiquitin as a marker of cell Injury in nonalcoholic steatohepatitis [J].
Banner, BF ;
Savas, L ;
Zivny, J ;
Tortorelli, K ;
Bonkovsky, HL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (06) :860-866
[8]   A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis [J].
Basaranoglu, M ;
Acbay, O ;
Sonsuz, A .
JOURNAL OF HEPATOLOGY, 1999, 31 (02) :384-384
[9]   Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes [J].
Berson, A ;
De Beco, V ;
Lettéron, P ;
Robin, MA ;
Moreau, C ;
El Kahwaji, J ;
Verthier, N ;
Feldmann, G ;
Fromenty, B ;
Pessayre, D .
GASTROENTEROLOGY, 1998, 114 (04) :764-774
[10]   Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis [J].
Bonkovsky, HL ;
Jawaid, Q ;
Tortorelli, K ;
LeClair, P ;
Cobb, J ;
Lambrecht, RW ;
Banner, BF .
JOURNAL OF HEPATOLOGY, 1999, 31 (03) :421-429